Загрузка...
Development and prevalence of castration-resistant prostate cancer subtypes
BACKGROUND: Castration-resistant prostate cancer (CRPC) occurs when prostate cancer (CaP) progresses under therapy-induced castrate conditions. Several mechanisms have been proposed to explain this acquired resistance, many of which are driven by androgen receptor (AR). Recent findings, however, sub...
Сохранить в:
| Опубликовано в: : | Neoplasia |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Neoplasia Press
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7522286/ https://ncbi.nlm.nih.gov/pubmed/32980775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2020.09.002 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|